GROUP ONE TRADING, L.P. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,094
-92.3%
113
-92.5%
0.00%
Q4 2022$53,469
-94.9%
1,499
-95.1%
0.00%
-100.0%
Q3 2022$1,039,000
-41.4%
30,696
-49.9%
0.00%
-33.3%
Q2 2022$1,772,000
+4119.0%
61,272
+4657.1%
0.00%
Q1 2022$42,000
-42.5%
1,288
-48.2%
0.00%
Q4 2021$73,000
-37.1%
2,488
-42.7%
0.00%
Q3 2021$116,000
+182.9%
4,339
+173.9%
0.00%
Q1 2021$41,000
+115.8%
1,584
+112.6%
0.00%
Q4 2020$19,000
-26.9%
745
-41.0%
0.00%
Q3 2020$26,000
-90.5%
1,262
-89.1%
0.00%
-100.0%
Q2 2020$274,000
-33.5%
11,550
-49.6%
0.00%
-66.7%
Q1 2020$412,000
-78.6%
22,926
-71.8%
0.00%
-76.9%
Q4 2019$1,927,000
+573.8%
81,260
+680.0%
0.01%
+550.0%
Q3 2019$286,000
+65.3%
10,418
+99.8%
0.00%0.0%
Q2 2019$173,000
-9.9%
5,214
-4.7%
0.00%0.0%
Q1 2019$192,000
-64.6%
5,474
-66.5%
0.00%
-60.0%
Q4 2018$543,000
+393.6%
16,357
+646.2%
0.01%
+400.0%
Q3 2018$110,000
+511.1%
2,192
+380.7%
0.00%
Q4 2017$18,000
-50.0%
456
-49.8%
0.00%
Q3 2017$36,000
-81.0%
908
-87.8%
0.00%
-100.0%
Q4 2016$189,000
+38.0%
7,471
-16.9%
0.00%0.0%
Q1 2016$137,000
-86.1%
8,986
-90.0%
0.00%
-86.7%
Q2 2014$984,000
-66.6%
89,882
-72.7%
0.02%
-70.0%
Q1 2014$2,948,000
+96.1%
329,801
+65.5%
0.05%
+117.4%
Q4 2013$1,503,000199,2730.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 921,962$33,402,6835.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 423,500$15,326,4654.28%
ARMISTICE CAPITAL, LLC 4,350,000$157,600,5002.27%
S&T BANK/PA 223,775$8,1071.46%
Aristotle Capital Boston, LLC 1,155,149$41,851,0711.29%
Tributary Capital Management, LLC 353,671$12,813,5001.19%
Bridge City Capital, LLC 62,790$2,274,8821.14%
RICE HALL JAMES & ASSOCIATES, LLC 551,285$19,973,0561.14%
Intrinsic Edge Capital Management LLC 289,704$10,495,9761.05%
Parkman Healthcare Partners LLC 131,878$4,777,9401.04%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders